Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring

ERC (European Research Council)HORIZON-ERCID: 101043119
EC Contribution
€25,000
Consortium Size
1 orgs
Start Year
2022
Summary

Cardiovascular diseases are the leading cause of death globally. Monitoring heart functions and ischemia is critical for survival after cardiac surgery. Standard monitoring methods such as echocardiogram and ELISA blood test provide single-time measurements. They are available only in hospitals, and there is no continuous monitoring method after patients are discharged, leading to a high rate of recurrent heart failures and rehospitalization. Implantable medical devices are used for treatment of various disorders. However, their non-resorbable nature necessitates an implant removal surgery that puts additional risk of infection and stress on patients and limits their use in postoperative monitoring. Bioresorbable implants may soon revolutionize postoperative monitoring methods. The surgeon will implant a small patch onto the heart during surgery, enabling continuous cardiac monitoring and early alerts for heart failure. This will reduce sudden attacks, rehospitalizations, and financial burden of health care. Then, once the monitoring period ends, triggering with a light source will dissolve the implant; thus, providing a significant second chance for the survivors of cardiac failure without the burden of secondary surgery. The technological advancements to bring this vision to the clinic are not available yet. 2ND-CHANCE will facilitate this vision by building components of next-generation wireless implants with triggered bioresorption for cardiac surgery through ground-breaking approaches. This interdisciplinary project aims to develop 1) bioresorbable sensors compatible with the in-body environment, 2) battery-free ultrasonic communication, and 3) encapsulation layer with triggered bioresorption, followed by 4) integration and animal tests. The versatility of the 2ND-CHANCE will also yield potential breakthroughs in fields where monitoring of tissues and biomarkers is crucial such as neurology and ophthalmology, and open new research perspectives.

Consortium (1)

Project Results (7)

Source: CORDIS, the EU research results database.

Publications (5)
An integrated and flexible ultrasonic device for continuous bladder volume monitoring
Nature Communications· 2024DOI
Alp Timucin Toymus, Umut Can Yener, Emine Bardakci, Özgür Deniz Temel, Ersin Koseoglu, Dincay Akcoren, Burak Eminoglu, Mohsin Ali, Rasim Kilic, Tufan Tarcan, Levent Beker
Near-Infrared Triggered Degradation for Transient Electronics
ACS Omega· 2024DOI
Emin Istif; Mohsin Ali; Elif Yaren Ozuaciksoz; Yagız Morova; Levent Beker
A Flexible and Biodegradable Piezoelectric‐Based Wearable Sensor for Non‐Invasive Monitoring of Dynamic Human Motions and Physiological Signals
Advanced Materials Technologies· 2023DOI
Mohsin Ali, Seyed Morteza Hoseyni, Ritu Das, Muhammad Awais, Ipek Basdogan, Levent Beker
A Wearable Touch‐Activated Device Integrated with Hollow Microneedles for Continuous Sampling and Sensing of Dermal Interstitial Fluid
Advanced Materials· 2023DOI
Taher Abbasiasl; Fariborz Mirlou; Hadi Mirzajani; Mohammad Javad Bathaei; Emin Istif; Narges Shomalizadeh; Rümeysa Emine Cebecioğlu; Ecem Ezgi Özkahraman; Umut Can Yener; Levent Beker
Journal of Interconnection Networks
Advanced Healthcare Materials· 2023DOI
Mohsin Ali; Mohammad Javad Bathaei; Emin Istif; Seyed Nasir Hosseini Karimi; Levent Beker
Deliverables (1)
Data Management Plan
Other Results (1)
Periodic Reporting for period 1 - 2ND-CHANCE (Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring)